Millennium Management’s Agilon Health AGL Stock Holding History

Millennium Management’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,444	Closed	-$2.04M	–	6054
2023 Q1	$2.04M	Buy	+3,444	New	+$1.93M	﹤0.01%	3414
2022 Q1	–	Sell	-5,400	Closed	-$3.65M	–	6841
2021 Q4	$3.65M	Buy	+5,400	New	+$3.29M	﹤0.01%	3202

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NPCM

North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Millennium Management's AGL Position: Q1 2026 in Review

Millennium Management sold out of Agilon Health (AGL) in Q1 2026, closing a stake of 18,051 shares — an estimated $311K sold.

Millennium Management first reported a position in AGL in Q3 2021 and held it in 16 quarters. The position peaked at $25.6M in Q4 2023. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

Millennium Management reported no remaining Agilon Health position as of Q1 2026 after selling out during the quarter.
Millennium Management sold 18,051 Agilon Health shares in Q1 2026, an estimated $311K.
Millennium Management first reported a position in Agilon Health in Q3 2021 and held it in 16 quarters.
Millennium Management's Agilon Health position peaked at $25.6M in Q4 2023.
97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.